in

OpenAI CEO to testify before Congress alongside ‘AI pause’ advocate and IBM exec

Details remain scarce concerning the hearing’s agenda. Its title, “Oversight of A.I.: Rules for Artificial Intelligence,” implies the discussion will center on safety and privacy, as does the roster of scheduled attendees.

Continue Reading on Coin Telegraph

Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge

Debt ceiling battle delays sweeping annual defense policy bill